
Sign up to save your podcasts
Or
This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.
4.1
2929 ratings
This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.
6,133 Listeners
4,238 Listeners
32,299 Listeners
3,481 Listeners
22,089 Listeners
2,174 Listeners
26,469 Listeners
3,369 Listeners
6,696 Listeners
9,272 Listeners
318 Listeners
29 Listeners
15,335 Listeners
3,365 Listeners
1,175 Listeners